TOS.TO : Summary for TSO3 INC - Yahoo Finance

Canadian Markets closed

TSO3 Inc. (TOS.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
3.00+0.08 (+2.74%)
At close: 3:54PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.92
Open2.96
Bid2.99 x
Ask3.00 x
Day's Range2.93 - 3.01
52 Week Range2.05 - 3.82
Volume140,492
Avg. Volume151,709
Market Cap276.09M
Beta0.90
PE Ratio (TTM)-60.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group3 days ago

    TSO3 to Report First Quarter 2017 Results and Hold Annual Meeting of Shareholders on Wednesday, May 10, 2017

    TSO3 to Report First Quarter 2017 Results and Hold Annual Meeting of Shareholders on Wednesday, May 10, 2017

  • PR Newswire3 days ago

    TSO3 to Report First Quarter 2017 Results and Hold Annual Meeting of Shareholders on Wednesday, May 10, 2017

    QUEBEC CITY, April 26, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, will report financial results for its first fiscal quarter 2017 ended March 31, 2017.  Financial results will be issued in a press release on May 10, prior to the meeting. TSO3 will also hold its Annual Meeting of shareholders at 10:30 a.m. (EDT) on the same day.

  • PR Newswire10 days ago

    TSO3 to publish innovative validation method linked to sterilization of multichannel endoscopes in upcoming issue of the Canadian Journal of Infection Control

    QUÉBEC CITY, Canada and MYRTLE BEACH, USA, April 19, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, announced today that an original paper has been accepted for publication in the peer-reviewed Canadian Journal of Infection Control.  The paper describes the first and only gravity based direct inoculation (intentional bacterial contamination) method which meets the requirements of US regulators for confirmation that the inoculum is deposited into the middle of each channel of complex multichannel endoscopes. Additionally, the paper describes the TSO3 STERIZONE® low temperature sterilization system and its ability to sterilize such scopes. The paper highlights how this new method satisfied the requirements of the US Food and Drug Administration (FDA) for targeted inoculation and recovery efficacy, and also demonstrates that the STERIZONE® VP4 Sterilizer can achieve a sterility assurance level (SAL) of 10-6 using this enhanced method.